143 related articles for article (PubMed ID: 2510272)
1. Rioprostil in the short-term treatment of duodenal ulcer: a multicentre double-blind trial vs. cimetidine.
Bianchi Porro G; Parente F; Hentschel E; Bennani A; Sebti F; Cherkaoui A; Demyttenaere M; Gouerou H; Blasi A; Darnis F
Scand J Gastroenterol Suppl; 1989; 164():219-23. PubMed ID: 2510272
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of rioprostil, 300 micrograms b.d., in the treatment of duodenal ulcer: a double-blind, controlled multicentre clinical study vs. ranitidine.
Coremans G; Vantrappen G; Businger JA; Demol P
Scand J Gastroenterol Suppl; 1989; 164():198-205; discussion 205-6. PubMed ID: 2510268
[TBL] [Abstract][Full Text] [Related]
3. Rioprostil vs. ranitidine in duodenal ulcer healing: a double-blind multicentre trial.
Lavignolle A; Raillat A; Slama JL; Viteau JM; Veyres B; Lebourgeois P; Audigier JC; Abgrall J; Parlier H; Vray M
Scand J Gastroenterol Suppl; 1989; 164():194-7. PubMed ID: 2510267
[TBL] [Abstract][Full Text] [Related]
4. Treatment of duodenal ulcer with rioprostil: a randomized multicentre double-blind study.
Boucekkine T; Meknini B; Bitoun A; Prunièras F; Khedis A; de Lauture D; Rotenberg A; Molinie C; Roux M; Gauthier A
Scand J Gastroenterol Suppl; 1989; 164():191-3. PubMed ID: 2510266
[TBL] [Abstract][Full Text] [Related]
5. Rioprostil, a new prostaglandin E1 analogue, in the once-daily treatment of acute duodenal ulcer: a comparison with ranitidine.
Businger JA; Miglio F; Gasbarrini T; Vismans FJ; Geraedts AA; Stocker H
Scand J Gastroenterol Suppl; 1989; 164():161-7; discussion 167-8. PubMed ID: 2510261
[TBL] [Abstract][Full Text] [Related]
6. A single evening dose of rioprostil, 600 micrograms, in the treatment of acute duodenal ulcers.
Dammann HG; Dreyer M; Müller P; Simon B; Demol P
Scand J Gastroenterol Suppl; 1989; 164():215-8. PubMed ID: 2510271
[TBL] [Abstract][Full Text] [Related]
7. Rioprostil, a new prostaglandin E1 analogue, in the once-daily treatment for the prevention of duodenal ulcer recurrence: a comparison with ranitidine.
Businger JA; Fumagalli I; Michel H; Delas N; Stocker H
Scand J Gastroenterol Suppl; 1989; 164():152-9; discussion 159-60. PubMed ID: 2510260
[TBL] [Abstract][Full Text] [Related]
8. Rioprostil and ranitidine in the prevention of duodenal ulcer relapse.
Rampal P; Raillat A; Viteau JM; Slama JL; Lavignolle A; Bedenne L; Veyres B; Toulet J; Vray M; Prunieras F
Scand J Gastroenterol Suppl; 1989; 164():146-50; discussion 150-1. PubMed ID: 2510259
[TBL] [Abstract][Full Text] [Related]
9. Rioprostil in the healing of duodenal ulceration: a short report.
Whorwell PJ
Scand J Gastroenterol Suppl; 1989; 164():214. PubMed ID: 2510270
[TBL] [Abstract][Full Text] [Related]
10. Rioprostil in the acute and long-term treatment of peptic ulcers: a review.
Dammann HG; Dreyer M; Müller P; Simon B
Scand J Gastroenterol Suppl; 1989; 164():207-11; discussion 212-3. PubMed ID: 2510269
[TBL] [Abstract][Full Text] [Related]
11. Treatment of benign gastric ulcer: a comparative clinical trial of rioprostil and ranitidine.
Quinton A; Goldfain D; Weber F; Briaud M; Plane D; Bancons J; Monneris R; Audigier JC; Arnal JC; Lacoste D
Scand J Gastroenterol Suppl; 1989; 164():178-82; discussion 182-3. PubMed ID: 2510264
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of rioprostil, 300 micrograms b.d., in the treatment of gastric ulcer: a comparison vs. ranitidine, 150 mg b.d., in a randomized multicentre study.
Rutgeerts P; Vantrappen G; Businger JA; Demol P; Simon B; Barbier P
Scand J Gastroenterol Suppl; 1989; 164():184-90. PubMed ID: 2510265
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic use of rioprostil, 600 micrograms o.d., in duodenal peptic ulcer during its active uncomplicated phase].
Benvestito V; Benvestito S; Guida M; Mariani L
Minerva Dietol Gastroenterol; 1988; 34(3):191-5. PubMed ID: 3143950
[No Abstract] [Full Text] [Related]
14. Endoscopic evaluation of rioprostil in the management of non-steroidal anti-inflammatory drug-induced gastritis: an interim analysis.
Caldwell JR; Weaver AL; Brown SK; McCormack GH
Scand J Gastroenterol Suppl; 1989; 164():239-41. PubMed ID: 2510275
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic and therapeutic role of rioprostil in NSAIDs induced gastroduodenal lesions.
Paladini G; Fabiani MG; Tosato F; Maggiolo F
Scand J Gastroenterol Suppl; 1989; 164():242-5; discussion 245-6. PubMed ID: 2510276
[TBL] [Abstract][Full Text] [Related]
16. Rioprostil in the treatment of duodenal erosions.
Guslandi M; Ballarin E; Tittobello A
Scand J Gastroenterol Suppl; 1989; 164():174-6; discussion 176-7. PubMed ID: 2510263
[TBL] [Abstract][Full Text] [Related]
17. Drug safety of rioprostil in patients with active gastric or duodenal ulcer.
Corsing C; Demol P
Scand J Gastroenterol Suppl; 1989; 164():232-7; discussion 237-8. PubMed ID: 2510274
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandins, smoking, and duodenal ulcer relapse.
Maggiolo F; Ohnmeiss H
Gastroenterology; 1988 Jul; 95(1):256. PubMed ID: 3131180
[No Abstract] [Full Text] [Related]
19. Protective effect of rioprostil on indomethacin-induced lesions of gastric and duodenal mucosa in healthy volunteers.
Vlahov V; Kirkov V; Popov P; Gerova Z
Scand J Gastroenterol Suppl; 1989; 164():169-73. PubMed ID: 2510262
[TBL] [Abstract][Full Text] [Related]
20. Rioprostil 600 micrograms nocte: high duodenal ulcer healing rates, low incidence of side effects.
Dammann HG; Dreyer M; Walter TA; Müller P; Simon B
Prog Clin Biol Res; 1987; 242():289-93. PubMed ID: 3118383
[No Abstract] [Full Text] [Related]
[Next] [New Search]